Which legislative/regulatory issue will be most important in 2008?
A. Reimbursement of drugs and devices -- 11%
B. Postmarket monitoring of drugs and devices -- 37%
C. Drug and device companies' gifts to doctors -- 7%
D. Universal health care -- 45%
This story published in FDLI SmartBrief on 12/20/2007
Get stories like these delivered daily for FREE:
|
FDLI SmartBrief
Designed specifically for professionals involved in the food and drug law community, FDLI SmartBrief is a FREE daily e-mail newsletter. It provides the latest need-to-know news and industry information that maximizes your time, giving you an edge over your competition. Learn more |
|